Effects of Victoza® Versus Lyxumia® on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid Secretion
Status:
Terminated
Trial end date:
2018-07-23
Target enrollment:
Participant gender:
Summary
The present study will compare lixisenatide and liraglutide in a population of subjects with
T2DM not optimally controlled on OADs and / or insulin, which is the target population for
these medications.